Bio-protocol最新文献

The antibody-uptake assay is a commonly used technique to monitor endocytosis of integral membrane proteins including transmembrane and glycosylphosphatidylinositol-anchored proteins (GPI-APs). The antibody-uptake assay typically involves incubating live cells with fluorophore-conjugated antibodies directed against the extracellular domain of the integral membrane protein of interest. Antibody uptake is then detected by flow cytometry or confocal microscopy. However, these detection modalities may be inaccessible to some labs or require extensive training to operate. Thus, we developed an easy and novel sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot-based approach to the antibody-uptake assay that exploits the strong affinity between biotin and streptavidin. Instead of incubating cells with fluorophore-conjugated antibodies to monitor antibody uptake, our assay involves incubating cells with biotinylated antibodies, processing the cell lysates for western blot, and probing the membrane with detectably conjugated streptavidin. From preparation to quantification, this protocol requires less hands-on time than other approaches and is amenable to small-scale drug or siRNA screens. Here, we demonstrate the utility of our approach using the well-characterized misfolded GPI-AP, YFP-tagged C179A mutant of prion protein (YFP-PrP*), as our model substrate. YFP-PrP* constitutively traffics to the plasma membrane (PM), where it binds to anti-GFP antibody, and immediately undergoes endocytosis to lysosomes. To validate our protocol, we present measurements of antibody uptake under conditions known to enhance or inhibit YFP-PrP*'s traffic to the PM. Using this assay, we present new evidence that, under certain conditions, YFP-PrP* is able to undergo degradation via a pathway that does not involve exposure on the cell surface. Key features • Incubate live cells with biotinylated primary antibody and a lysosomal degradation inhibitor, process lysates for western blot, and probe the blot with detectably conjugated streptavidin. • Fast, easy, and semi-quantitative assay to test whether integral membrane proteins are degraded through pathways involving exposure on the plasma membrane. • Conduct screens for small molecules, siRNAs, or conditions that promote or inhibit traffic of your protein of interest through the plasma membrane. • Pair this protocol with a synchronized trafficking assay to detect changes in the rate of proteins traversing the plasma membrane.

Telomere length maintenance is strongly linked to cellular aging, as telomeres progressively shorten with each cell division. This phenomenon is well-documented in mitotic, or dividing, cells. However, neurons are post-mitotic and do not undergo mitosis, meaning they lack the classical mechanisms through which telomere shortening occurs. Despite this, neurons retain telomeres that protect chromosomal ends. The role of telomeres in neurons has gained interest, particularly in the context of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), where aging is a major risk factor. This has sparked interest in investigating telomere maintenance mechanisms in post-mitotic neurons. Nevertheless, most existing telomere analysis techniques were developed for and optimized using mitotic cells, posing challenges for studying telomeres in non-dividing neuronal cells. Thus, this protocol adapts an already established technique, the combined immunofluorescence and telomere fluorescent in situ hybridization (IF-FISH) on mitotic cells to study the processes occurring at telomeres in cortical neurons of the mouse ALS transgenic model, TDP-43 rNLS. Specifically, it determines the occurrence of DNA damage and the alternative lengthening of telomeres (ALT) mechanism through simultaneous labeling of the DNA damage marker, γH2AX, or the ALT marker, promyelocytic leukemia (PML) protein, together with telomeres. Therefore, the protocol enables the visualization of DNA damage (γH2AX) or the ALT marker (PML) concurrently with telomeres. This technique can be successfully applied to brain tissue and enables the investigation of telomeres specifically in cortical neurons, rather than in bulk tissue, offering a significant advantage over Southern blot or qPCR-based techniques. Key features • This protocol enables the labeling of telomeres in mouse brain tissue prepared from paraffin-embedded brain sections. • This method facilitates concurrent labeling of proteins that are colocalized at telomere sites.

DNA methylation is a crucial epigenetic modification that influences gene expression and plays a role in various biological processes. High-throughput sequencing techniques, such as bisulfite sequencing (BS-seq) and enzymatic methyl sequencing (EM-seq), enable genome-wide profiling of DNA methylation patterns with single-base resolution. In this protocol, we present a bioinformatics pipeline for analyzing genome-wide DNA methylation. We outline the step-by-step process of the essential analyses, including quality control using FASTQ for BS- and EM-seqs raw reads, read alignment with commonly used aligners such as Bowtie2 and BS-Seeker2, DNA methylation calling to generate CGmap files, identification of differentially methylated regions (DMRs) using tools including MethylC-analyzer and HOME, data visualization, and post-alignment analyses. Compared to existing workflows, this pipeline integrates multiple steps into a single protocol, lowering the technical barrier, improving reproducibility, and offering flexibility for both plant and animal methylome studies. To illustrate the application of BS-seq and EM-seq, we demonstrate a case study on analyzing a mutant in Arabidopsis thaliana with a mutation in the met1 gene, which encodes a DNA methyltransferase, and results in global CG hypomethylation and altered gene regulation. This example highlights the biological insights that can be gained through systematic methylome analysis. Our workflow is adaptable to any organism with a reference genome and provides a robust framework for uncovering methylation-associated regulatory mechanisms. All scripts and detailed instructions are provided in GitHub repository: https://github.com/PaoyangLab/Methylation_Analysis. Key features • Provides a comprehensive pipeline for genome-wide DNA methylation analysis. • Step-by-step command line for DMR identification and post-analysis with visualization.

Cellular phenomena such as signal integration and transmission are based on the correct spatiotemporal organization of biomolecules within the cell. Therefore, the targeted manipulation of such processes requires tools that can precisely induce the localizations and interactions of the key players relevant to these processes with high temporal resolution. Chemically induced dimerization (CID) techniques offer a powerful means to manipulate protein function with high temporal resolution and subcellular specificity, enabling direct control over cellular behavior. Here, we present the detailed synthesis and application of dual SLIPT and dual SLIPT^NVOC, which expand the SLIPT (self-localizing ligand-induced protein translocation) platform by incorporating a dual-ligand CID system. Dual SLIPT and dual SLIPT^NVOC independently sort into the inner leaflet of the plasma membrane via a lipid-like anchoring motif, where they present the two headgroup moieties trimethoprim (TMP) and HaloTag ligand (HTL), which recruit and dimerize any two ^iK6eDHFR- and HOB-tagged proteins of interest (POIs). Dual-SLIPT^NVOC furthermore enables this protein dimerization of POIs at the inner leaflet of the plasma membrane in a pre-determined order and light-controlled manner. In this protocol, we detail the synthetic strategy to access dual SLIPT and dual SLIPT^NVOC, while also providing the underlying rationale for key design and synthetic decisions, with the aim of offering a streamlined, accessible, and broadly implementable methodology. In addition to the detailed synthesis, we present representative applications and typical experimental outcomes and recommend strategies for data analysis to support effective use of the system. Notably, dual SLIPT and dual SLIPT^NVOC represent the first CID systems to emulate endogenous lipidation-driven membrane targeting, while retaining hallmark advantages of CID technology-the precision over POI identity, recruitment sequence, high spatiotemporal control, and "plug-and-play" flexibility. Key features • Expands the original SLIPT technology [1] by enabling plasma membrane (PM) recruitment of any two POIs and their dimerization. • Dual SLIPT^NVOC as the first self-localizing lipid-like probe to induce PM recruitment and dimerization, with a defined recruitment sequence. • Optimal use case at low probe concentrations: the system mimics physiological lipid-mediated dimerization without globally saturating the plasma membrane with recruited POIs. • Descriptions of solid phase peptide synthesis and chemical synthesis for facile access to dual SLIPT and dual SLIPT^NVOC, experimental results, and their analysis.

When plants undergo senescence or experience carbon starvation, leaf cells degrade proteins in the chloroplasts on a massive scale via autophagy, an evolutionarily conserved process in which intracellular components are transported to the vacuole for degradation to facilitate nutrient recycling. Nonetheless, how portions of chloroplasts are released from the main chloroplast body and mobilized to the vacuole remains unclear. Here, we developed a method to observe the autophagic transport of chloroplast proteins in real time using confocal laser-scanning microscopy on transgenic plants expressing fluorescently labeled chloroplast components and autophagy-associated membranes. This protocol enabled us to track changes in chloroplast morphology during chloroplast-targeted autophagy on a timescale of seconds, and it could be adapted to monitor the dynamics of other intracellular processes in plant leaves. Key features • This protocol enables real-time monitoring of chloroplast morphology in living Arabidopsis leaves. • The method is based on confocal microscopy of transgenic plants that express fluorescent protein markers for specific organelles or suborganellar compartments. • We used this protocol to monitor the piecemeal autophagic degradation of chloroplasts, but it could also be extended to other intracellular phenomena.

In the field of osteoarthritis (OA), the identification of reliable diagnostic and prognostic biomarkers in patients with hip lesions such as femoroacetabular impingement (FAI) could have an immeasurable value. Calcium crystal detection in synovial fluids (SFs) is one tool currently available to diagnose patients with rheumatologic disorders. Crystals, such as monosodium urate (MSU) and calcium pyrophosphate (CPP), are identified qualitatively by compensated polarized light, whereas basic calcium phosphate (BCP) crystals are visualized under conventional light microscopy by Alizarin red S (ARS) staining. Here, we present an efficient and straightforward protocol to quantify calcium crystals by spectrophotometric analysis in human osteoarthritic SFs after staining with ARS. The type and size of the different crystal species are confirmed by environmental scanning electron microscopy (ESEM). Key features • This protocol provides a quantitative assay to measure calcium crystals in human synovial fluids. • ARS is specific for hydroxyapatite, calcium phosphate, tetrasodium pyrophosphate, sodium phosphate, calcium chloride/pyrophosphate dihydrate, and oxalate crystals; does not show any combination with SFs components. • The standard curve for crystal quantification was prepared with a synthetic hydroxyapatite, which allows to prepare a series of stable and reproducible standards. • The analysis with ESEM determines the elemental composition of all visible particles without any pretreatment of the biological sample prior to observation.

Accurate labeling of excitatory postsynaptic sites remains a major challenge for high-resolution imaging due to the dense and sterically restricted environment of the postsynaptic density (PSD). Here, we present a protocol utilizing Sylites, 3 kDa synthetic peptide probes that bind with nanomolar affinity to key postsynaptic markers, PSD-95 and Gephyrin. eSylites (excitatory Sylites) specifically target the PDZ1 and PDZ2 domains of PSD-95, enabling precise and efficient labeling of excitatory postsynaptic density (ePSD). In contrast, iSylites (inhibitory Sylites) bind to the dimerizing E-domain of the Gephyrin C-terminus, allowing selective visualization of inhibitory postsynaptic density (iPSD). Their small size reduces linkage error and enhances accessibility compared to conventional antibodies, enabling clear separation of PSD-95 nanodomains in super-resolution microscopy. The protocol is compatible with co-labeling using standard antibodies and integrates seamlessly into multichannel immunocytochemistry workflows for primary neurons and brain tissue. This method enables robust, reproducible labeling of excitatory synapses with enhanced spatial resolution and can be readily adapted for expansion microscopy or live-cell applications. Key features • Protocol for using synthetic bidendate peptide probes: eSylites [1] for PSD-95 at excitatory synapses and iSylites [2] for Gephyrin at inhibitory synapses. • Compatible with standard antibody staining for multiplexed imaging of primary neurons and tissue sections. • Reduces linkage error, improving spatial resolution and nanodomain visualization in super-resolution microscopy.

This protocol describes the isolation and flow cytometric analysis of extracellular vesicles (EVs) derived from red blood cells, endothelial cells, and platelets in human peripheral blood. The protocol includes steps for preparing platelet-free plasma, fluorescent antibody staining, gating strategies, and technical controls. This protocol was developed within a study on EV release in snakebite-associated thrombotic microangiopathy; the protocol addresses challenges such as variable autofluorescence and heterogeneity in EV origin. It is flexible and can be adapted for alternative antibody panels targeting different cell populations or EV subtypes, including leukocyte-derived EVs. Key features • Bead-free, two-step plasma preparation enhances extracellular vesicle yield, reduces platelet contamination, and improves purity compared with conventional isolation methods for small-volume clinical samples. • Reduced autofluorescence by compensation strategy using flow cytometry. • Gating strategies to detect distinct EV populations derived from red cells, endothelial cells, and platelets. • Validated in healthy donors and patients, enabling reproducible detection of EVs with broad downstream compatibility for flow cytometric applications.

Xenobiotics, including environmental pollutants such as bisphenols, phthalates, and parabens, are widely present in food, cosmetics, packaging, and water. These compounds can reach the gastrointestinal tract and interact with the gut microbiota (GM), a complex microbial community that plays a key role in host immunity, metabolism, and barrier function. The GM engages in bidirectional communication with the host via the production of bioactive metabolites, including short-chain fatty acids, neurotransmitter precursors, and bile acid derivatives. Dysbiosis induced by xenobiotics can disrupt microbial metabolite production, impair gut barrier integrity, and contribute to the development of systemic disorders affecting distant organs such as the liver or brain. On the other hand, the GM can biotransform xenobiotics into metabolites with altered bioactivity or toxicity. In vitro models of the human GM offer a valuable tool to complement population-based and in vivo studies, enabling controlled investigation of causative effects and underlying mechanisms. Here, we present an optimized protocol for the collection, cryopreservation, and cultivation of human GM under strictly anaerobic conditions for toxicomicrobiomics applications. The method allows the assessment of xenobiotic-GM interactions in a cost-effective and ethically sustainable way. It is compatible with a wide range of downstream applications, including 16S rDNA sequencing, metabolomics, and endocrine activity assays. The protocol has been optimized to minimize oxygen exposure to less than 2 min, ensuring the viability of obligate anaerobes that dominate the gut ecosystem. This approach facilitates reproducible, mechanistic studies on the impact of environmental xenobiotics on human GM. Key features • Strict anaerobic handling of human fecal samples: The protocol maintains anaerobic conditions from collection to cultivation, with oxygen exposure limited to less than 2 min. • Pooled-sample inoculum for reproducibility: Cryopreserved inoculum derived from pooled donor samples reduces inter-individual variability and ensures high reproducibility across experiments. • Compatibility with diverse downstream applications: The protocol supports a wide range of analyses, including 16S rDNA sequencing, untargeted metabolomics, SCFA profiling, and host-GM interaction studies. • High-throughput capacity: Up to 192 samples can be cultured simultaneously, enabling efficient large-scale experiments.